台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效

智基

(6294)
可現股當沖
  • 股價
    100.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    67
  • 產業
    上櫃 文化創意指數▲3.16%
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/26     後一日»

券商獲利排行 - 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  13.04%306.50.1306.5-18220117.5117.5117.5100.5
  14.47%1870187-10011117.5117.5117.5100.5
  14.47%85085-505117.50117.5100.5
  14.47%51051-303117.50117.5100.5
  9.65%34034-213117.5117.5117.5100.5
  14.29%33.5033.5-202117.30117.3100.5
  14.47%17017-101117.50117.5100.5
  14.47%17017-101117.50117.5100.5
  14.47%17017-101117.50117.5100.5
  14.47%17017001117.5117.5117.5100.5
  14.47%17017-101117.50117.5100.5
  14.47%17017-101117.50117.5100.5
  14.10%16.5016.5-1011170117100.5
  14.10%16.5016.5-1011170117100.5
  14.10%16.5016.5-1011170117100.5
  14.10%16.5016.5-1011170117100.5
   000000117.5117.50100.5
   000000117.5117.5117.5100.5
   000000117.50117.5100.5
   0000001170117100.5
   000000117.50117.5100.5
   0000001180118100.5
   0000001181180100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   0000001170117100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001180118100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
  0.00%000011117.5117.5117.5100.5
   0000001181180100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001180118100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001181180100.5
   000000117.5117.50100.5
   000000117.50117.5100.5
   0000001180118100.5

券商虧損排行 - 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -14.47%-1190-119770117.5117.50100.5
  -14.47%-1020-102660117.5117.50100.5
  -14.47%-1020-102560117.5117.5117.5100.5
  -14.47%-850-85550117.5117.50100.5
  -14.56%-68.50-68.5440117.6117.60100.5
  -14.47%-680-68440117.5117.50100.5
  -14.19%-66.50-66.5440117.1117.10100.5
  -14.47%-510-51330117.5117.50100.5
  -14.47%-340-34220117.5117.50100.5
  -14.47%-340-34220117.5117.50100.5
  -14.47%-340-34220117.5117.50100.5
  -14.10%-330-332201171170100.5
  -14.47%-170-17110117.5117.50100.5
  -14.47%-170-17110117.5117.50100.5
  -14.47%-170-17110117.5117.50100.5
  -14.47%-170-17110117.5117.50100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001180118100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
  0.00%000011117.5117.5117.5100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001181180100.5
   000000117.5117.50100.5
   000000117.50117.5100.5
   0000001180118100.5
   000000117.5117.50100.5
   000000117.5117.50100.5
   0000001180118100.5
   000000117.50117.5100.5
   000000117.5117.50100.5
   000000117.5117.5117.5100.5
   0000001170117100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   000000117.50117.5100.5
   0000001181180100.5
   0000001170117100.5
   000000117.50117.5100.5
   0000001180118100.5
   0000001181180100.5
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音